Canaan (NASDAQ:CAN), a leading provider of high-performance computing solutions and a pioneer in Bitcoin mining hardware, has released its unaudited operational update for March 2026.
XTI Aerospace (NASDAQ:XTIA) has released its financial results for the full year 2025 and provided an optimistic outlook for 2026, marking its first comprehensive reporting period since the $40 million acquisition of Drone Nerds in late 2025.
Stereotaxis (NYSE:STXS), a pioneer in innovative robotic technologies for the treatment of arrhythmias and endovascular disease, announced today that it has entered into a definitive agreement to acquire Robocath.
Viant Technology (NASDAQ:DSP), a prominent player in AI-powered programmatic advertising, announced today that it has entered into a definitive agreement to acquire TVision Insights.
Raytheon, an RTX (NYSE:RTX) business, achieved a major milestone in its next-generation sensing portfolio on April 15, 2026, with the successful completion of the first flight test of the RAIVEN Staring sensing system.
60 Degrees Pharmaceuticals (NASDAQ:SXTP) announced on April 15, 2026, a strategic partnership with Runway Health to make ARAKODA (tafenoquine) available to U.S. travelers via a dedicated telehealth platform.
Immutep (NASDAQ:IMMP), a clinical-stage biotechnology company developing LAG-3 immunotherapies, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, eftilagimod alfa (efti), for the treatment of soft tissue sarcoma (STS).
NOV (NYSE:NOV) announced today that it has lowered its financial guidance for the first quarter of 2026, citing unforeseen operational and logistical disruptions caused by the escalating conflict in the Middle East.
Arbutus Biopharma (NASDAQ:ABUS), a clinical-stage biopharmaceutical company specializing in chronic infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for imdusiran (AB-729) for the treatment of chronic hepatitis B (cHBV).
Bitdeer Technologies Group (NASDAQ:BTDR) has released its operational update for March 2026, highlighting a period of hyper-growth in both its artificial intelligence infrastructure and core Bitcoin mining operations.
Mako Mining (NASDAQ:MAKO) has announced record-breaking production results for the first quarter ended March 31, 2026, marking a pivotal shift in the company’s financial and operational trajectory.
Arrive AI (NASDAQ:ARAI), a developer of autonomous delivery infrastructure and the "smart mailbox" for the drone era, has reported its financial results for the full year and fourth quarter ended December 31, 2025.
